Hysterectomy and Mobility decreased
Summary:
Mobility decreased is found among people with Hysterectomy, especially for people who are female, 60+ old.
The study analyzes which people have Mobility decreased with Hysterectomy. It is created by eHealthMe based on reports of 20 people who have Hysterectomy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Hysterectomy?
Hysterectomy is found to be associated with 716 drugs and 1,377 conditions by eHealthMe. Check the latest studies of Hysterectomy.
What is Mobility decreased?
Mobility decreased (ability to move is reduced) is found to be associated with 1,774 drugs and 1,636 conditions by eHealthMe. Check the latest studies of Mobility decreased.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
20 people who have Hysterectomy and Mobility Decreased are studied.

Gender of people who have Hysterectomy and experienced Mobility Decreased *:
- female: 100 %
- male: 0.0 %
Age of people who have Hysterectomy and experienced Mobility Decreased *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 5.88 %
- 50-59: 41.18 %
- 60+: 52.94 %
Common co-existing conditions for these people *:
- Bladder Disorder: 5 people, 25.00%
- Depression: 5 people, 25.00%
- Pain: 5 people, 25.00%
- Stress And Anxiety: 4 people, 20.00%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 20.00%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 20.00%
- Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 15.00%
- Urinary Tract Infection: 3 people, 15.00%
- Psoriasis (immune-mediated disease that affects the skin): 2 people, 10.00%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.00%
Common drugs taken by these people *:
- Premarin: 10 people, 50.00%
- Gabapentin: 6 people, 30.00%
- Humira: 6 people, 30.00%
- Estradiol: 5 people, 25.00%
- Toviaz: 4 people, 20.00%
- Baclofen: 4 people, 20.00%
- Ocrevus: 3 people, 15.00%
- Naproxen: 3 people, 15.00%
- Myrbetriq: 3 people, 15.00%
- Celebrex: 3 people, 15.00%
Common symptoms for these people *:
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 7 people, 35.00%
- Crying: 6 people, 30.00%
- Joint Pain: 5 people, 25.00%
- Memory Loss: 5 people, 25.00%
- Rashes (redness): 4 people, 20.00%
- Weakness: 4 people, 20.00%
- Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 3 people, 15.00%
- Muscle Tightness: 3 people, 15.00%
- Fall: 3 people, 15.00%
- Kidney Stones: 3 people, 15.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Mobility decreased?
- Check whether Mobility decreased is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Hysterectomy (13,002 reports)
- Mobility decreased (83,538 reports)
All the drugs that are associated with Mobility decreased:
- Mobility decreased (1,774 drugs)
All the conditions that are associated with Mobility decreased:
- Mobility decreased (1,636 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Mobility decreased and Hysterectomy, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Dipyridamole and Magnesium - 3 seconds ago
- Citalopram Hydrobromide and Lisinopril drug interactions for men aged 50-59 - 6 seconds ago
- Nexium vs. Prozac, side effect and effectiveness comparison - 17 seconds ago
- Neupogen and Oxycontin drug interactions for women aged 50-59 - 37 seconds ago
- Centrax vs. Depakote Er, side effect and effectiveness comparison - 39 seconds ago
- Vitamin K and Protonix drug interactions for men aged 60+ - 42 seconds ago
- Amlodipine and Imodium drug interactions for men aged 40-49 - a minute ago
- Omega-3 Marine Triglycerides and Exhaustion, Fatigue, Lethargy, Tiredness, Weariness for Women aged 60+ - a minute ago
- Omega-3 Marine Triglycerides and Weariness for Women aged 60+ - a minute ago
- Omega-3 Marine Triglycerides and Tiredness for Women aged 60+ - a minute ago